| Line Item | 2024-11-03 | Y/Y |
|---|---|---|
| Revenue | $51.57B | +44.0% |
| Cost of Revenue | $19.07B | +71.3% |
| Gross Profit | $32.51B | +31.7% |
| R&D Expense | $9.31B | +77.2% |
| SG&A Expense | $4.96B | +211.5% |
| Operating Income | $13.46B | -16.9% |
| Interest Expense | $3.95B | +143.7% |
| Pre-tax Income | $9.92B | -34.3% |
| Income Tax | $3.75B |
| Line Item | 2024-11-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.35B | -34.1% |
| Accounts Receivable | $4.42B | +40.0% |
| Inventory | $1.76B | -7.3% |
| Current Assets | $19.59B | -6.0% |
| Total Assets | $165.65B | +127.3% |
| Current Liabilities | $16.70B | +125.5% |
| Long-term Debt | $66.30B | +76.2% |
| Line Item | 2024-11-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.96B | +10.4% |
| Capital Expenditures | $548.0M | +21.2% |
| Investing Cash Flow | -$23.07B | -3248.3% |
| Financing Cash Flow | -$1.73B | +88.9% |
| Free Cash Flow | $19.41B | +10.1% |
| +269.3% |
| Net Income | $5.89B | -58.1% |
| EPS (Basic) | $1.27 | -96.3% |
| EPS (Diluted) | $1.23 | -96.3% |
| Total Liabilities |
| $97.97B |
| +100.5% |
| Stockholders' Equity | $67.68B | +182.1% |